PPCB

PROPANC BIOPHARMA INC by Propanc Biopharma, Inc. (PPCB)

About PROPANC BIOPHARMA INC by Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.

Details

Daily high
$5.00
Daily low
$4.94
Price at open
$4.94
52 Week High
$222.00
52 Week Low
$1.25
Market cap
127.7M
Dividend yield
0.00%
Volume
1,770
Avg. volume
613
P/E ratio
-.02

PROPANC BIOPHARMA INC by Propanc Biopharma, Inc. News

Details

Daily high
$5.00
Daily low
$4.94
Price at open
$4.94
52 Week High
$222.00
52 Week Low
$1.25
Market cap
127.7M
Dividend yield
0.00%
Volume
1,770
Avg. volume
613
P/E ratio
-.02